Preprint DKFZ-2023-02689

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Oncogenic RAS-Pathway Activation Drives Oncofetal Reprogramming and Creates Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2023

bioRxiv () [10.1101/2023.10.27.563754]  GO

This record in other databases:

Please use a persistent id in citations: doi:


Contributing Institute(s):
  1. Epigenomik (B370)
  2. Translationale Medizinische Onkologie (B340)
  3. KKE Neuroonkologie (B320)
  4. A010 Stammzellen und Krebs (A010)
  5. scOpen Lab (W192)
  6. A012 Experimentelle Hämatologie (A012)
  7. W610 Core Facility Omics IT (W610)
Research Program(s):
  1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2023
Click to display QR Code for this record

The record appears in these collections:
Document types > Reports > Preprints
Public records
Publications database

 Record created 2023-12-13, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)